New Group CEO

Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead Growth

Chiesi has appointed David Khougazian as its Group Chief Executive Officer, succeeding Interim Group CEO Jean-Marc Bellemin who has been leading the Group since 2026. Khougzian joins Chiesi following a distinguished international career spanning over 25 years. He previously served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering. Chiesis aims to reach Net-Zero greenhouse gases emissions by 2035. The company remains committed to executing its patient-centric strategy, advancing innovation across its therapeutic areas, and delivering sustainable growth for the benefit of patients, healthcare systems, communities and the planet.